PortfoliosLab logoPortfoliosLab logo
2269.HK vs. 9926.HK
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

2269.HK vs. 9926.HK - Performance Comparison

The chart below illustrates the hypothetical performance of a HK$10,000 investment in WuXi Biologics (2269.HK) and Akeso Inc (9926.HK). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

2269.HK vs. 9926.HK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
2269.HK
WuXi Biologics
11.26%78.64%-40.54%-50.54%-35.33%-9.26%165.16%
9926.HK
Akeso Inc
24.34%86.31%30.71%7.91%26.47%-10.53%56.38%

Returns By Period

In the year-to-date period, 2269.HK achieves a 11.26% return, which is significantly lower than 9926.HK's 24.34% return.


2269.HK

1D
0.34%
1M
-5.46%
YTD
11.26%
6M
-16.87%
1Y
33.26%
3Y*
-9.57%
5Y*
-19.75%
10Y*

9926.HK

1D
0.93%
1M
41.14%
YTD
24.34%
6M
0.50%
1Y
59.66%
3Y*
52.58%
5Y*
21.21%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

2269.HK vs. 9926.HK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

2269.HK
2269.HK Risk / Return Rank: 6060
Overall Rank
2269.HK Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
2269.HK Sortino Ratio Rank: 5757
Sortino Ratio Rank
2269.HK Omega Ratio Rank: 5858
Omega Ratio Rank
2269.HK Calmar Ratio Rank: 6161
Calmar Ratio Rank
2269.HK Martin Ratio Rank: 6262
Martin Ratio Rank

9926.HK
9926.HK Risk / Return Rank: 7171
Overall Rank
9926.HK Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
9926.HK Sortino Ratio Rank: 6868
Sortino Ratio Rank
9926.HK Omega Ratio Rank: 6767
Omega Ratio Rank
9926.HK Calmar Ratio Rank: 7979
Calmar Ratio Rank
9926.HK Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

2269.HK vs. 9926.HK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WuXi Biologics (2269.HK) and Akeso Inc (9926.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


2269.HK9926.HKDifference

Sharpe ratio

Return per unit of total volatility

0.63

0.94

-0.31

Sortino ratio

Return per unit of downside risk

1.12

1.55

-0.44

Omega ratio

Gain probability vs. loss probability

1.16

1.21

-0.05

Calmar ratio

Return relative to maximum drawdown

0.98

2.46

-1.48

Martin ratio

Return relative to average drawdown

2.38

4.38

-2.00

2269.HK vs. 9926.HK - Sharpe Ratio Comparison

The current 2269.HK Sharpe Ratio is 0.63, which is lower than the 9926.HK Sharpe Ratio of 0.94. The chart below compares the historical Sharpe Ratios of 2269.HK and 9926.HK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


2269.HK9926.HKDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.63

0.94

-0.31

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.30

0.31

-0.61

Sharpe Ratio (All Time)

Calculated using the full available price history

0.27

0.51

-0.24

Correlation

The correlation between 2269.HK and 9926.HK is 0.48, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

2269.HK vs. 9926.HK - Dividend Comparison

Neither 2269.HK nor 9926.HK has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

2269.HK vs. 9926.HK - Drawdown Comparison

The maximum 2269.HK drawdown since its inception was -92.95%, which is greater than 9926.HK's maximum drawdown of -82.37%. Use the drawdown chart below to compare losses from any high point for 2269.HK and 9926.HK.


Loading graphics...

Drawdown Indicators


2269.HK9926.HKDifference

Max Drawdown

Largest peak-to-trough decline

-92.95%

-82.37%

-10.58%

Max Drawdown (1Y)

Largest decline over 1 year

-28.29%

-46.13%

+17.84%

Max Drawdown (5Y)

Largest decline over 5 years

-92.95%

-82.37%

-10.58%

Current Drawdown

Current decline from peak

-75.98%

-20.58%

-55.40%

Average Drawdown

Average peak-to-trough decline

-42.31%

-32.86%

-9.45%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.73%

25.95%

-11.22%

Volatility

2269.HK vs. 9926.HK - Volatility Comparison

The current volatility for WuXi Biologics (2269.HK) is 14.41%, while Akeso Inc (9926.HK) has a volatility of 18.27%. This indicates that 2269.HK experiences smaller price fluctuations and is considered to be less risky than 9926.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


2269.HK9926.HKDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.41%

18.27%

-3.86%

Volatility (6M)

Calculated over the trailing 6-month period

31.76%

36.44%

-4.68%

Volatility (1Y)

Calculated over the trailing 1-year period

54.68%

65.63%

-10.95%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

66.79%

70.19%

-3.40%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.32%

69.47%

-9.15%

Financials

2269.HK vs. 9926.HK - Financials Comparison

This section allows you to compare key financial metrics between WuXi Biologics and Akeso Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in HKD except per share items